Drug Profile
4-Azidothymidine
Alternative Names: ADRTLatest Information Update: 14 Nov 2006
Price :
$50
*
At a glance
- Originator Roche Palo Alto LLC
- Class Antiretrovirals; Nucleosides
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Mar 1995 No-Development-Reported for HIV infections treatment in USA (PO)